Literature DB >> 16554492

The case for rituximab in AIDS-related lymphoma.

Kieron Dunleavy, Wyndham H Wilson, Lawrence D Kaplan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16554492     DOI： 10.1182/blood-2005-09-3885

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  4 in total

1.  Non-Hodgkin's lymphoma among patients infected with human immunodeficiency virus: the experience of a single center in Brazil.

Authors:  Paula Yurie Tanaka; Luis Fernando Pracchia; Edenilson Eduardo Calore
Journal:  Int J Hematol       Date:  2006-11       Impact factor: 2.490

Review 2.  How I treat HIV-associated lymphoma.

Authors:  Kieron Dunleavy; Wyndham H Wilson
Journal:  Blood       Date:  2012-02-15       Impact factor: 22.113

3.  The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma.

Authors:  Kieron Dunleavy; Richard F Little; Stefania Pittaluga; Nicole Grant; Alan S Wayne; Jorge A Carrasquillo; Seth M Steinberg; Robert Yarchoan; Elaine S Jaffe; Wyndham H Wilson
Journal:  Blood       Date:  2010-02-03       Impact factor: 22.113

Review 4.  Update on HIV lymphoma.

Authors:  Ariela Noy
Journal:  Curr Oncol Rep       Date:  2007-09       Impact factor: 5.075
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.